Patient No.
|
Diagnosisa
|
SBR Gradeb
|
Age
|
ERc
|
PRc
|
Malignant lymph nodesd
|
---|
1
|
IDC
|
III/III
|
43
|
-
|
-
|
NS
|
2
|
IDC
|
III/III
|
55
|
-
|
-
|
0/11
|
3
|
IDC
|
III/III
|
67
|
-
|
-
|
0/17
|
4
|
IDC
|
III/III
|
49
|
-
|
-
|
NS
|
5
|
IDC
|
III/III
|
59
|
+++
|
+++
|
0/9
|
6
|
IDC
|
III/III
|
75
|
-
|
-
|
0/10
|
7
|
IDC
|
II/III
|
60
|
-
|
-
|
15/15
|
8
|
IDC
|
III/III
|
34
|
-
|
-
|
1/15
|
9
|
IDC
|
III/III
|
70
|
++++
|
-
|
0/5
|
10
|
IDC
|
II/III
|
69
|
na
|
na
|
0/16
|
11
|
IDC
|
III/III
|
49
|
++
|
+
|
0/8
|
-
a IDC: infiltrating duct carcinoma b SBR: Scarff-Bloom-Richardson histological grading system c ER and PR concentration codes: - receptor values less than 24 + receptor values between 25 and 99 ++ receptor values between 100 and 249 +++ receptor values between 250 and 549 ++++ receptor values > 550 d Number of lymph nodes assessed as malignant out of total number examined na: not available NS: No lymph nodes submitted with specimen